• <tr id='XHHI8C'><strong id='XHHI8C'></strong><small id='XHHI8C'></small><button id='XHHI8C'></button><li id='XHHI8C'><noscript id='XHHI8C'><big id='XHHI8C'></big><dt id='XHHI8C'></dt></noscript></li></tr><ol id='XHHI8C'><option id='XHHI8C'><table id='XHHI8C'><blockquote id='XHHI8C'><tbody id='XHHI8C'></tbody></blockquote></table></option></ol><u id='XHHI8C'></u><kbd id='XHHI8C'><kbd id='XHHI8C'></kbd></kbd>

    <code id='XHHI8C'><strong id='XHHI8C'></strong></code>

    <fieldset id='XHHI8C'></fieldset>
          <span id='XHHI8C'></span>

              <ins id='XHHI8C'></ins>
              <acronym id='XHHI8C'><em id='XHHI8C'></em><td id='XHHI8C'><div id='XHHI8C'></div></td></acronym><address id='XHHI8C'><big id='XHHI8C'><big id='XHHI8C'></big><legend id='XHHI8C'></legend></big></address>

              <i id='XHHI8C'><div id='XHHI8C'><ins id='XHHI8C'></ins></div></i>
              <i id='XHHI8C'></i>
            1. <dl id='XHHI8C'></dl>
              1. <blockquote id='XHHI8C'><q id='XHHI8C'><noscript id='XHHI8C'></noscript><dt id='XHHI8C'></dt></q></blockquote><noframes id='XHHI8C'><i id='XHHI8C'></i>
                Stock Code:002675
                Yantai Dongcheng Beifang Pharmaceutical Co.,Ltd
                YOUR LOCATION:HOME >> BRANCH

                            Established in Feb. 1993 with registered capital of 50 million RMB, Yantai Dongcheng Beifang Pharmaceuticals Co., Ltd. is a wholly owned subsidiary of Dongcheng Biochemicals covering a planning land of 200 thousand square meters and now has enabled half of the space. In May 2012, Yantai Dongcheng Biochemicals and its subsidiaries went public in Shenzhen.

                            The company currently mainly produces freeze-dried powder injection (including hormones) and small capacity injection, owns production

                approval numbers for 17 products and 30 specifications. Our main products include: Defibrase for injection, Menotropins for injection, Chorionic Gonadotrophin for injection, Methionine and Vitamin B1 for injection, Levocarnitine for injection, and Hydrocortisone Sodium Succinate for injection etc.



                            Quality has always been priority of Beifang Pharmaceuticals, and we attach great importance to implementation of GMP. The company not only has passed CFDA GMP inspection in 2001, 2005 and 2010 respectively, also established a sound management system that covers all key GMP requirements, organizes regular GMP self-inspectionand production equipment safety self-inspection to ensure product quality. And in May 2014, the new factory has passed the revised GMP inspection. As for hardware, Beifang is equipped with a full range of advanced imported test instruments, including American HPLC, Japanese HPLC and Total Organic Carbon (TOC) Analyzer, Domestic Advanced Gas Chromatograph, AAS, Ultraviolet Spectrophotometer, Moisture Measuring Instrument, Swiss Metter Accuracy Electrical Scale, etc.



                            Since inception, the company has been actively introducing and cultivating talents, committed to new drug research and emphasizing on product quality. With normative management system, the company pays insurances and housing fund for employees and provides all kinds of welfares such as paid annual vacation, festival allowance, birthday present, transportation and housing allowance. There are 120 employees and 80% of them hold a junior college degree or above. Employees in technical and quality testing department all hold a junior college degree or above and corresponding technical title. Highly qualified personnel determine the abundant strength of company’s research and quality test technology. Relying on strong R & D power, as well as continuously developing and introducing new products, we’ll constantly breathing new life to the company’s development.

                            In 2013, DCB has invested 477 million RMB to build new Beifang Pharmaceutical Industry Park, which has passed new CFDA GMP inspection. The designed annual capacity is: (1) 14.93 million Chorionic Gonadotrophin for injection, 10 million Hydrocortisone Sodium Succinate for injection and 1.2 million Menotropins for injection; (2) 30 million Heparin Sodium for injection, 25 million Chondroitin Sulfate for injection and 25 million water injection; (3) 500 million Glucosamine Chondroitin Sulfate tablets and 125 million Cytochrome C tablets; (4) 200 million Glucosamine Chondroitin Sulfate capsules for health care. It will increase about 1824.05 million annually after the new industrial park totally put into operation.

                             Until now, the first-stage of the new industrial park has been completed as planning. It covers an area of 100 thousand square meters and the building covers an area of 32.4 thousand square meters. The new industrial park has passed CFDA GMP inspection and officially operates in May 2014.

                Tel: 0535-3978598

                Administration Department: 0535-3975220

                Sales Department: 0535-6385399



                CONTACT US
                Address:No.7 ChangBaiShan Road, Yantai Development Zone, ShanDong, China